Glucagon I pp 399-417 | Cite as

Glucagon and Amino Acid Metabolism

  • G. F. CahillJr.
  • T. T. Aoki
  • R. J. Smith
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 66 / 1)

Abstract

Glucagon is thought to play two major metabolic roles (UNGER and ORCI 1981). One, as shown over 30 years ago by Sutherland and associates (Sutherland 1950; Sutherland et al. 1968), is to increase blood glucose levels by initiating hepatic glycogenolysis. The other is to promote gluconeogenesis, thus serving to maintain glucose production, even in the face of increased insulin levels, such as after a high protein meal when insulin and glucagon are both increased. Therefore, glucagon has a very significant metabolic role, especially in carbohydrate deficiency, be it in the fed or in the fasted state. Glucagon has also been found to decrease amino acid levels after its infusion in humans (Fig. 1) and experimental animals (Helmer et al. 1957; Weinges 1959; Landau and Lugibihl 1960; Bromer and Chance 1969; Marliss et al. 1970; Aoki et al. 1974). This effect is apparent in subjects with glucagon-producing tumors, who have been found to have strikingly low concentrations of all or almost all amino acids (Mallinson et al. 1974; Holst 1978, 1979; Kessinger et al. 1977; Boden et al. 1978; Riddle et al. 1978; Holst et al. 1979; Stacpoole et al. 1981; Bhathena et al. 1981). This response could result both from increased hepatic amino acid trapping and, possibly, from a global effect of glucagon in regulating the gradients of amino acids across all cells, or even in regulating protein synthesis and breakdown.

Keywords

Lactate Lipase Adenosine Serine Proline 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adibi SA (1968) Influence of dietary deprivation on plasma concentration of free amino acids of man. J Appl Physiol 25: 52–57PubMedGoogle Scholar
  2. Aikawa T, Matsutaka H, Takezawa K, Ishikawa E (1972) Gluconeogenesis and amino acid metabolism. I. Comparison of various precursors for hepatic gluconeogenesis in vivo. Biochim Biophys Acta 279: 234–244PubMedGoogle Scholar
  3. Aoki TT, Müller WA, Brennan MF, Cahill GF Jr (1974) Effect of glucagon on amino acid and nitrogen metabolism in fasting man. Metabolism 23: 805–814PubMedGoogle Scholar
  4. Aoki TT, Toews CJ, Rossini AA, Ruderman NB, Cahill GF Jr (1975) Gluconeogenic substrate levels in fasting man. Adv Enzyme Regul 13: 329–336PubMedGoogle Scholar
  5. Ashford TP, Porter KR (1962) Cytoplasmic components in hepatic cell lysosomes. J Cell Biol 12: 198–202PubMedGoogle Scholar
  6. Askanazi J, Fürst P, Michelson CB, Elwyn DH, Vinnars E, Gump FE, Stinchfield FE, Kinney JM ( 1980 a) Muscle and plasma amino acids after injury. Hypocaloric glucose vs. amino acid infusion. Ann Surg 191: 465–472PubMedGoogle Scholar
  7. Askanazi J, Carpentier YA, Michelsen CB, Elwyn DH, Fürst P, Kantrowitz LR, Gump FE, Kinney JM ( 1980 b) Muscle and plasma amino acids following injury. Influence of intercurrent infection. Ann Surg 192: 78–85PubMedGoogle Scholar
  8. Beatty CH, Peterson RD, Bocek RM, Craig NC, Weleber R (1963) Effect of glucagon on incorporation of glycine-C14 into protein of voluntary skeletal muscle. Endocrinology 73: 721–726PubMedGoogle Scholar
  9. Bergstrom J, Fürst P, Noree L-O, Vinnars E (1974) The intracellular free amino acid con-centration in human muscle tissue. J Appl Physiol 36: 693–697PubMedGoogle Scholar
  10. Bhathena SJ, Higgins GA, Recant L (1981) Glucagonoma and glucagonoma syndrome. In: Unger RH, Orci L (eds) Glucagon. Elsevier/North Holland, Amsterdam Oxford New York, pp 413–438Google Scholar
  11. Boden G, Owen OE (1977) Familial hyperglucagonemia - an autosomal dominant disorder. N Engl J Med 296: 53–538Google Scholar
  12. Boden G, Owen OE, Rezvani I, Elfenbein EI, Quickel KE (1977) An islet cell carcinoma containing glucagon and insulin. Chronic glucagon excess and glucose homeostasis. Diabetes 26: 128–137PubMedGoogle Scholar
  13. Boden G, Wilson RM, Owen OE (1978) Effects of chronic glucagon excess on hepatic metabolism. Diabetes 27: 643–648PubMedGoogle Scholar
  14. Boden G, Master RW, Rezvani I, Palmer JP, Lobe TE, Owen OE (1980) Glucagon deficiency and hyperaminocidemia after total pancreatectomy. J Clin Invest 65: 706–716PubMedGoogle Scholar
  15. Bromer WW, Chance RE (1969) Zinc glucagon depression of blood amino acids in rabbits. Diabetes 18: 748–754PubMedGoogle Scholar
  16. Buse MG, Biggers JF, Drier C, Buse JF (1973) The effect of epinephrine, glucagon, and the nutritional state on the oxidation of branched chain amino acids and pyruvate by isolated hearts and diaphragms of the rat. J Biol Chem 248: 697–706PubMedGoogle Scholar
  17. Cahill GF Jr (1971) Physiology of insulin in man. Diabetes 20: 785–799PubMedGoogle Scholar
  18. Cahill GF Jr, Owen OE (1968) Some observations on carbohydrate metabolism in man. In: Dickens F, Randle PJ, Whelan WJ (eds) Carbohydrate metabolism and its disorders, chap 16. Academic Press, New York London, pp 497–556Google Scholar
  19. Cahill GF Jr, Felig P, Marliss EB (1970) Some physiological principles of parenteral nutrition. In: Fox CL Jr, Nahas GG (eds) Fluid replacement in the surgical patient: a symposium, 1969. Grune and Stratton, New York, pp 286–295Google Scholar
  20. Cahill GF Jr, Marliss EB, Aoki TT (1972) Insulin and muscle protein. In: Steiner DF, Freinkel N (eds) Endocrinology. American Physiology Society, Washington, DC (Handbook of physiology, sect 7, vol 1, pp 563–577 )Google Scholar
  21. Cahill GF Jr, Aoki TT, Smith RJ (1981) Amino acid cycles in man. Curr Top Cell Regul 18: 389–400PubMedGoogle Scholar
  22. Carlsten A, Hallgren B, Jagenburg R, Svanborg A, Werko L (1966) Amino acids in plasma in diabetes. I. The effect of insulin on arterial levels. Acta Med Scand 179: 361–370PubMedGoogle Scholar
  23. Chambers JW, Georg RH, Bass AD (1968) Effects of catecholamines and glucagon on amino acid transport in the liver. Endocrinology 83: 1185–1192PubMedGoogle Scholar
  24. Christensen HN (1973) On the development of amino acid transport systems. Fed Proc 2: 19–28Google Scholar
  25. Christensen HN (1979) Exploiting amino acid structure to learn about membrane transport. Adv Enzymol 49: 41–101PubMedGoogle Scholar
  26. Christensen HN (1981) Membrane domination of biological energy exchanges: a message of the 1978 Nobel award in chemistry. Perspect Biol Med 24: 358–373PubMedGoogle Scholar
  27. Crofford DB, Felts PW, Lacy WW (1964) Effect of glucose infusion on the individual free amino acids in man. Proc Soc Exp Biol Med 117: 11–14PubMedGoogle Scholar
  28. Cuthbertson DP (1932) Observations on the disturbance of metabolism produced by injury to the limbs. Biochem J 25: 233–246Google Scholar
  29. Deri JJ, Williams PE, Steiner KE, Cherrington AD (1981) Altered ability of the liver to produce glucose following a period of glucagon deficiency. Diabetes 30: 490–495PubMedGoogle Scholar
  30. DeRosa G, Swick RW (1975) Metabolic implications of the distribution of the alanine aminotransferase isozymes. J Biol Chem 250: 7961–7967PubMedGoogle Scholar
  31. Deuel HJ Jr, Sandiford K, Sandiford I, Boothby WM (1926) Deposit protein: the effect of thyroxin on the deposit protein after reduction of the nitrogen excretion to a minimal level by a prolonged protein-free diet. J Biol Chem 67:XXIII–XXIVGoogle Scholar
  32. Dieterle PM, Brawand F, Moser UK, Walter P (1978) Alanine metabolism in rat liver mitochondria. Eur J Biochem 88: 467–473PubMedGoogle Scholar
  33. Exton JH (1972) Gluconeogenesis. Metabolism 21: 945–990PubMedGoogle Scholar
  34. Exton JH, Park CR (1967) Control of gluconeogenesis in liver. I. General features of gluconeogenesis in the perfused livers of rats. J Biol Chem 242: 2622–2636PubMedGoogle Scholar
  35. Exton JH, Park CR (1968) Control of gluconeogenesis in liver. II. Effects of glucagon, cat-echolamines, and adenosine 3’,5’-monophosphate on gluconeogenesis in the perfused rat liver. J Biol Chem 243: 4189–4196PubMedGoogle Scholar
  36. Exton JH, Park CR (1969) Control of gluconeogenesis in liver. III. Effects of lactate, pyruvate, fructose, glucagon, epinephrine and adenosine 3’,5’-monophosphate on gluconeogenic intermediates in the perfused rat liver. J Biol Chem 244: 1424–1433PubMedGoogle Scholar
  37. Farah A, Tuttle R (1960) Studies on the pharmacology of glucagon. J Pharmacol Exp Ther 129: 49–55PubMedGoogle Scholar
  38. Fehlmann M, LeCam A, Kitabgi P, Rey J-F, Freychet P ( 1979 a) Regulation of amino acid transport in the liver. Emergence of a high affinity transport system in isolated hepatocytes from fasting rats. J Biol Chem 254: 401–407PubMedGoogle Scholar
  39. Fehlmann M, LeCam A, Freychet P ( 1979 b) Insulin and glucagon stimulation of amino acid transport in isolated rat hepatocytes. Synthesis of a high affinity component of transport. J Biol Chem 254: 10431–10437PubMedGoogle Scholar
  40. Fehlmann M, Samson M, Koch KS, Leffert HL, Freychet P (1981) The effect of amiloride on hormonal regulation of amino acid transport in isolated and cultured adult rat hepatocytes. Biochim Biophys Acta 642: 88–95PubMedGoogle Scholar
  41. Felig P (1975) Amino acid metabolism in man. Annu Rev Biochem 44: 933–955PubMedGoogle Scholar
  42. Felig P, Owen OE, Wahren J, Cahill GF Jr (1969) Amino acid metabolism during prolonged starvation. J Clin Invest 48: 584–594PubMedGoogle Scholar
  43. Felig P, Marliss E, Ohman J, Cahill GF Jr (1970) Plasma amino acid levels in diabetic ketoacidosis. Diabetes 19: 727–729PubMedGoogle Scholar
  44. Foa PP, Dunbar JC, Klein SP, Levy SH, Malik MA, Campbell BB, Foa NL (1980) Reactive hypoglycemia and A-cell (“pancreatic”) glucagon deficiency in the adult. JAMA 244: 2281–2285PubMedGoogle Scholar
  45. Freychet P, LeCam A (1977) Amino acid transport in isolated hepatocytes: effect of glucagon. Ciba Found Symp 55: 247–262PubMedGoogle Scholar
  46. Fürst P, Bergstrom J, Chao L, Larsson J, Liljedahl SO, Neuhauser M, Schildt B, Vinnars E (1979) Influence of amino acid supply on nitrogen and amino acid metabolism in severe trauma. Acta Chir Scand [Suppl] 494: 136–141Google Scholar
  47. Gerich JE, Lorenzi M, Bier DM, Schneider V, Tsalikian E, Karam JH, Forsham PH (1975) Prevention of human diabetic keotacidosis by somatostatin. Evidence for an essential role of glucagon. N Engl J Med 292: 985–989PubMedGoogle Scholar
  48. Gotlin RW, Silver HK (1970) Neonatal hypoglycemia, hyperinsulinism and absence of pancreatic alpha cells. Lancet 1: 1346Google Scholar
  49. Grey N, McGuigan JE, Kipnis DM (1970) Neutralization of endogenous glucagon by high titer glucagon antiserum. Endocrinology 86: 1383–1388PubMedGoogle Scholar
  50. Guder W, Hepp KD, Wieland O (1970) The catabolic action of glucagon in rat liver. Biochim Biophys Acta 222: 593PubMedGoogle Scholar
  51. Hait G, Kypson J, Massik R (1972) Amino acid incorporation into myocardium: effect of insulin, glucagon, and dibutyryl 3’,5’-AMP. Am J Physiol 222: 40–408Google Scholar
  52. Helmer OM, Kirtley WR, Ridolfo AS (1957) Clinical and metabolic changes induced by glucagon in patients with rheumatoid arthritis. J Lab Clin Med 50: 824Google Scholar
  53. Hinton P, Allison SP, Littlejohn S, Lloyd J (1971) Insulin and glucose to reduce catabolic response to injury in burned patients. Lancet 1: 767–769PubMedGoogle Scholar
  54. Hoist J J (1978) Glucagonomas. In: Bloom SR (ed) Gut hormones. Churchill Livingstone, Edinburgh London, pp 599–694Google Scholar
  55. Hoist JJ (1979) Gut endocrine tumour syndromes. Clin Endocrinol Metab 8: 413–432Google Scholar
  56. Hoist JJ, Helland S, Ingemannson S, Pedersen NB, Von Schenk H (1979) Functional studies in patients with the glucagonoma syndrome. Diabetologia 17: 151–156Google Scholar
  57. Kessinger A, Lemon HM, Foley JF (1977) The glucagonoma syndrome and its management. J Surg Oncol 9: 419–424PubMedGoogle Scholar
  58. Kilberg MS, Neuhaus OW (1977) Hormonal regulation of hepatic amino acid transport. J Supramol Struct 6: 191–204PubMedGoogle Scholar
  59. Kinney JM, Felig P (1979) The metabolic response to injury and infection. In: DeGroot LJ et al. (eds) Endocrinology. Grune and Stratton, New York, pp 1963–1986Google Scholar
  60. Kinney JM, Long CL, Gump FE, Duke JH Jr (1968) Tissue composition of surgical patients. I. Elective operation. Ann Surg 168: 459–474Google Scholar
  61. Koerker DJ, Ruch W, Chideckel E, Palmer J, Goodner CJ, Ensinck J, Gale CC (1974) Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 184: 482–484PubMedGoogle Scholar
  62. Kollee LA, Monnens LA, Cejka V, Wilms RH (1978) Persistent neonatal hypoglycemia due to glucagon deficiency. Arch Dis Child 53: 422–424PubMedGoogle Scholar
  63. Krebs HA (1969) The role of equilibria in the regulation of metabolism. Curr Top Cell Regul 6: 45–55Google Scholar
  64. Kruty F, Gvozdjak A, Bada V, Niederland TR, Gvozdjak J, Kaplan M (1978) The effect of glucagon on the heart muscle: relation between metabolic processes and contractility. Biochem Pharmacol 27: 2153–2155PubMedGoogle Scholar
  65. Landau RL, Lugibihl K (1960) Effect of glucagon on concentration of several free amino acids in plasma. Metabolism 18: 265–276Google Scholar
  66. Lawson LJ (1965) Parenteral nutrition in surgery. Br J Surg 52: 795–799PubMedGoogle Scholar
  67. LeCam A, Freychet P (1976) Glucagon stimulates the A system for neutral amino acid transport in isolated hepatocytes of the adult rat. Biochem Biophys Res Commun 72: 893–901Google Scholar
  68. Levey GS, Epstein SE (1969) Activation of adenyl cyclase by glucagon in cat and human heart. Circ Res 24: 151–156PubMedGoogle Scholar
  69. Levy LJ, Zarowitz H, Bleicher SJ, Spergel G (1969) Possible combined alpha and beta cell deficiency. Clin Res 17: 590Google Scholar
  70. Long CL, Spencer JL, Kinney JM, Geiger JW (1971) Carbohydrate metabolism in man: effects of elective operations and major injury. J Appl Physiol 31: 110–116PubMedGoogle Scholar
  71. Loreti L, Klein SP, Foa PP (1974) Hypoglycemia associated with glucagon insufficiency. Clin Res 22: 475Google Scholar
  72. MacDonald M, Neufeldt N, Park BN, Berger M, Ruderman NB (1976) Alanine metabolism and gluconeogenesis in the rat. Am J Physiol 231: 619–625PubMedGoogle Scholar
  73. Mallinson CH, Bloom SR, Warin AP, Salmon PR, Cox B (1974) A glucagonoma syndrome. Lancet 2: 1–5PubMedGoogle Scholar
  74. Manchester KL (1970) Control by insulin of amino acid accumulation in muscle. Biochem J 117: 457–465PubMedGoogle Scholar
  75. Marliss EB, Aoki TT, Unger RH, Soeldner JS, Cahill GF Jr (1970) Glucagon levels and metabolic effects in fasting man. J Clin Invest 49: 2256–2270PubMedGoogle Scholar
  76. Marliss EB, Aoki TT, Toews CJ, Felig P, Connon JJ, Kyner J, Huckabee WE, Cahill GF Jr (1972) Amino acid metabolism in lactic acidosis. Am J Med 52: 474–481PubMedGoogle Scholar
  77. McGavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin ME (1966) A glucagon-secreting alpha-cell carcinoma of the pancreas. N Engl J Med 274: 1408–1413PubMedGoogle Scholar
  78. Mialhe P (1958) Glucagon, insuline, et regulation endocrine de la glycemie chez le canard. Acta Endocrinol (Copenh) 28:(36)139Google Scholar
  79. Mikami SI, Ono K (1962) Glucagon deficiency induced by extirpation of alpha islets of the fowl pancreas. Endocrinology 71: 464–475PubMedGoogle Scholar
  80. Mortimer CH, Carr D, Lind T, Bloom SR, Mallinson CN, Schally AV, Tunbridge WMG, Yeomans L, Coy DH, Kastin A, Besser GM, Hale R (1974) Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet 1: 697–701PubMedGoogle Scholar
  81. Müller WA, Berger M, Suter P, Cuppers HJ, Reiter J, Wyss T, Berchtold P, Schmidt F, Assal J-P, Renold AE (1979) Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients. J Clin Invest 53: 820–827Google Scholar
  82. Munro HN (1964) General aspects of the regulation of protein metabolism by diet and by hormones. In: Munro HN, Allison JB (eds) Mammalian protein metabolism, vol 1. Academic, New York London, p 406Google Scholar
  83. Munro HN, Thomson WST (1953) Influence of glucose on amino acid metabolism. Metabolism 2: 354–361PubMedGoogle Scholar
  84. Norton J A, Kahn CR, Schiebinger R, Gorschboth C, Brennan MF (1979) Amino acid deficiency and the skin rash associated with glucagonoma. Ann Intern Med 91: 213–215PubMedGoogle Scholar
  85. Oxender DL, Christensen HN (1963) Distinct mediating systems for the transport of neutral amino acids by the Ehrlich cell. J Biol Chem 238: 3686–3699PubMedGoogle Scholar
  86. Parilla R, Jimenez M-K, Ayuso-Parrilla MS (1975) Glucagon and insulin control of gluconeogenesis in the perfused isolated rat liver. Effects on cellular metabolite distribution. Eur J Biochem 56: 375–383Google Scholar
  87. Parilla R, Jimenez M-K, Ayuso-Parrila MS (1976) Cellular redistribution of metabolites during glucagon and insulin control of gluconeogenesis in the isolated perfused rat liver. Arch Biochem Biophys 174: 1–12Google Scholar
  88. Peterson RD, Beatty CH, Bocek RM (1963) Effects of insulin and glucagon on carbohydrate and protein metabolism of adductor muscle and diaphragm. Endocrinology 72: 71–77PubMedGoogle Scholar
  89. Pozefsky T, Felig P, Soeldner JS, Cahill GF Jr (1968) Insulin blockade of amino acid release by human forearm tissues. Trans Assoc Am Physicians 82: 258–264Google Scholar
  90. Pozefsky T, Tancredi RG, Moxley RT, Dupre J, Tobin JD (1976) Metabolism in forearm tissues in man. Studies with glucagon. Diabetes 25: 125–128Google Scholar
  91. Pryor J, Berthet J (1960) The action of adenosine 3’,5’-monophosphate on the incorporation of leucine into liver proteins. Biochim Biophys Acta 43: 556–557PubMedGoogle Scholar
  92. Richards JR (1980) Current concepts in the metabolic responses in injury, infection and starvation. Proc Nutr Soc 39: 113–123PubMedGoogle Scholar
  93. Riddle MC, Golper TA, Fletcher WS, Ensinck JW, Smith PH (1978) Glucagonoma syndrome in a 19 year old woman. West J Med 129: 68–72PubMedGoogle Scholar
  94. Robison GA, Butcher RW, Sutherland EW (1971) Cyclic AMP. Academic, New York London, pp 232–284Google Scholar
  95. Rosa F (1971) Ultrastructural changes produced by glucagon, cyclic 3’,5’-AMP and epi-nephrine on perfused rat livers. Ultrastruc Res 34: 205Google Scholar
  96. Ross BD, Hems R, Krebs HA (1967) The rate of gluconeogenesis from various precursors in the perfused rat liver. Biochem J 102: 942–951PubMedGoogle Scholar
  97. Russell RCG, Walker CJ, Bloom SR (1975) Hyperglucagonemia in the surgical patient. Br Med J 1: 10–12PubMedGoogle Scholar
  98. Schimassek H, Gerok W (1965) Control of the levels of free amino acids in plasma by the liver. Biochem Z 342: 407–415Google Scholar
  99. Schimke RT (1970) Regulation of protein degradation in mammalian tissues. In: Munro HN, Allison JB (eds) Mammalian protein metabolism. Academic, New York London, pp 177–228Google Scholar
  100. Schworer CM, Mortimore GE (1979) Glucagon-induced autophagy and proteolysis in rat liver: mediation by selective deprivation of intracellular amino acids. Proc Natl Acad Sci USA 76: 3169–3173PubMedGoogle Scholar
  101. Sherwin RS, Tamborlane W, Hendler R, Sacca L, DeFronzo RA, Felig P (1977) Influence of glucagon replacement on the hyperglycemic and hyperketonemic response to prolonged somatostatin infusion in normal man. J Clin Endocrinol Metab 45: 1104–1107PubMedGoogle Scholar
  102. Siess EA, Wieland OH (1978) Glucagon-induced stimulation of 2-oxoglutarate metabolism in mitochondria from rat liver. FEBS Lett 93: 301–306PubMedGoogle Scholar
  103. Siess EA, Brocks DG, Lattke HK, Wieland OH (1977) Effect of glucagon on metabolite compartmentation in isolated rat liver cells during gluconeogenesis from lactate. Biochem J 166: 225–235PubMedGoogle Scholar
  104. Smith SR, Pozefsky T, Chhetri MK (1974) Nitrogen and amino acid metabolism in adults with protein-calorie malnutrition. Metabolism 23: 603–618PubMedGoogle Scholar
  105. Snodgrass PJ, Lin RC, Muller WA, Aoki TT (1978) Induction of urea cycle enzymes of rat liver by glucagon. J Biol Chem 253: 2748–2753PubMedGoogle Scholar
  106. Stacpoole PW, Jaspan J, Kasselberg AG, Halter SA, Polonsky K, Gluck FW, Liljenquist JE, Rabin D (1981) A familial glucagonoma syndrome. Genetic, clinical and biochemical features. Am J Med 70: 1017–1026PubMedGoogle Scholar
  107. Sutherland EW (1970) The effect of the hyperglycemic factor of the pancreas and of epinephrine on glycogenolysis. Recent Prog Horm Res 5: 441–463Google Scholar
  108. Sutherland EW, Robison GA (1969) The role of cyclic AMP in the control of carbohydrate metabolism. Diabetes 18: 797–819PubMedGoogle Scholar
  109. Sutherland EW, Robison GA, Butcher RW (1968) Some aspects of the biological role of adenosine 3’,5’-monophosphate (cyclic AMP). Circulation 37: 279–306Google Scholar
  110. Tews JK, Woodcock NH, Harper AE (1970) Stimulation of amino acid transport in rat liver slices by epinephrine, glucagon and adenosine–3’,5’-monophosphate. J Biol Chem 245: 3026–3032PubMedGoogle Scholar
  111. Tolbert MEM, Fain JN (1974) Studies on the regulation of gluconeogenesis in isolated rat liver cells by epinephrine and glucagon. J Biol Chem 249: 1162–1166PubMedGoogle Scholar
  112. Unger RH (1976) Diabetes and the alpha cell. The Banting Memorial Lecture 1975. Diabetes 25: 136–151PubMedGoogle Scholar
  113. Unger RH, Aguilar-Parada E, Muller WA, Eisentraut AM (1970) Studies of pancreatic alpha-cell function in normal and diabetic subjects. J Clin Invest 49: 837–848PubMedGoogle Scholar
  114. Unger RH, Dobbs RE, Orci L (1978) Insulin, glucagon, and somatostatin secretion in the regulation of metabolism. Annu Rev Physiol 40: 307–343PubMedGoogle Scholar
  115. Vidnes J (1976) Persistent hereditary neonatal hypoglycemia caused by glucagon deficiency. Pediatr Res 10: 881Google Scholar
  116. Vinnars E, Bergstrom J, Fürst P (1975) Influence of postoperative state on the intracellular free amino acids in human muscle tissue. Ann Surg 182: 665–671PubMedGoogle Scholar
  117. Wagner T, Spranger J, Brunck HJ (1969) Kongenitaler Alpha-Zellmangel als Ursache einer chronischen infantilen Hypoglykamie. Monatsschr Kinderheilk 117: 236–238Google Scholar
  118. Wahren J, Felig P (1976) Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet 2: 1213–1216PubMedGoogle Scholar
  119. Weinges KF (1959) Action of glucagon on the total amino acids in the serum. Arch Exp Pathol Pharmacol 237: 17–21Google Scholar
  120. Williamson JR (1967) Effects of fatty acids, glucagon and anti-insulin serum on the control of gluconeogenesis and ketogenesis in rat liver. Adv Enzyme Regul 5: 229–255PubMedGoogle Scholar
  121. Woodside KH, Mortimore GE (1970) Control of proteolysis in the perfused rat liver: influence of amino acids, insulin and glucagon ( Abstr ). Fed Proc 29: 379Google Scholar
  122. Young VR, Scrimshaw NS (1968) Endogenous nitrogen metabolism and plasma free amino acids in young adults given a protein-free diet. Br J Nutr 22: 9–20PubMedGoogle Scholar
  123. Zuppinger KA (1975) Hypoglycemia in childhood. Evaluation of diagnostic procedures. Monogr Paediatr 4. Karger, BaselGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • G. F. CahillJr.
  • T. T. Aoki
  • R. J. Smith

There are no affiliations available

Personalised recommendations